KRISTINE HERLEVI: Open Payments
NPI 1720302680 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 72 payments from 20 companies in 2025. Trend: 2023 $909 · 2024 $1,485 · 2025 $1,208
Food & beverage: $1,136Education: $72
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $190 |
| Janssen Biotech, Inc. | 6 | $176 |
| Galderma Laboratories, L.P. | 14 | $158 |
| ABBVIE INC. | 12 | $137 |
| PFIZER INC. | 5 | $91 |
| Organon LLC | 6 | $75 |
| UCB, Inc. | 2 | $75 |
| GENZYME CORPORATION | 2 | $42 |
| LEO Pharma Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, LITFULO, Bimzelx, Rhapsido, DUPIXENT, ADBRY.
Industry payments across NV — which companies pay providers there.
